Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 151.00 | 204.00 | 0.7402 | 0.1643 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 155.00 | 204.00 | 0.7598 | 0.2204 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 151.00 | 204.00 | 0.7402 | 0.1643 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 230.00 | 204.00 | 1.1275 | 1.4815 | |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 5 | 312.50 | 138.75 | 194.00 | 204.00 | 0.9510 | 0.8272 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 5 | 312.50 | 138.75 | 191.00 | 204.00 | 0.9363 | 0.7767 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 5 | 312.50 | 138.75 | 213.00 | 204.00 | 1.0441 | 1.1615 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 295.00 | 204.00 | 1.4461 | 2.8824 | |
| SK-BR-3 | Taxol | 0.31623 | uM | 5 | 312.50 | 138.75 | 144.00 | 204.00 | 0.7059 | 0.0691 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 5 | 312.50 | 138.75 | 189.00 | 204.00 | 0.9265 | 0.7434 |
| SK-BR-3 | Taxol | 1 | uM | 5 | 312.50 | 138.75 | 166.00 | 204.00 | 0.8137 | 0.3805 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 5 | 312.50 | 138.75 | 236.00 | 204.00 | 1.1569 | 1.5991 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 233.00 | 204.00 | 1.1422 | 1.5400 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 179.00 | 204.00 | 0.8775 | 0.5810 | |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 5 | 312.50 | 138.75 | 137.00 | 204.00 | 0.6716 | -0.0226 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 5 | 312.50 | 138.75 | 274.00 | 204.00 | 1.3431 | 2.3996 |
| SK-BR-3 | Methotrexate | 1 | uM | 5 | 312.50 | 138.75 | 254.00 | 204.00 | 1.2451 | 1.9664 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 5 | 312.50 | 138.75 | 169.00 | 204.00 | 0.8284 | 0.4257 |
| SK-BR-3 | Taxol | 0.001 | uM | 5 | 312.50 | 138.75 | 332.00 | 204.00 | 1.6275 | 3.8016 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 5 | 312.50 | 138.75 | 104.00 | 204.00 | 0.5098 | -0.4045 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 5 | 312.50 | 138.75 | 203.00 | 204.00 | 0.9951 | 0.9824 |
| SK-BR-3 | Methotrexate | 10 | uM | 5 | 312.50 | 138.75 | 193.00 | 204.00 | 0.9461 | 0.8103 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 5 | 312.50 | 138.75 | 130.00 | 204.00 | 0.6373 | -0.1105 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 5 | 312.50 | 138.75 | 135.00 | 204.00 | 0.6618 | -0.0481 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 196.00 | 204.00 | 0.9608 | 0.8612 |